Form 4: Acelyrin's Chief Legal Officer Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Amar Murugan, Chief Legal Officer of Acelyrin, Inc., sold 3,913 shares of common stock on March 17, 2025, to cover tax obligations related to vesting and settlement of restricted stock units.
Summary
- On March 17, 2025, Amar Murugan, the Chief Legal Officer of Acelyrin, Inc. (SLRN), sold 3,913 shares of common stock.
- The sale was executed to cover tax obligations arising from the vesting and settlement of restricted stock units.
- The shares were sold at a weighted average price of $2.744, with individual transactions ranging from $2.71 to $2.76.
- Following the transaction, Murugan directly owns 121,587 shares of Acelyrin common stock.
Sentiment
Score: 5
Explanation: This is a routine transaction (sell-to-cover for tax obligations) and doesn't necessarily indicate positive or negative sentiment about the company's future prospects.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders. Sell-to-cover transactions are common when restricted stock units vest, as they help employees manage their tax liabilities.
Stakeholder Impact
- The sale of shares by a company officer could have a minor impact on shareholder sentiment, but is unlikely to be significant given the reason for the sale.
Key Dates
| Date | Description |
|---|---|
| 03/17/2025 | Date of the stock sale transaction. |
| 03/19/2025 | Date of signature on the Form 4 filing. |
Keywords
Acelyrin, SLRN, Form 4, Insider Trading, Stock Sale, Murugan, Tax Obligations, Restricted Stock Units
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.